Last Updated: 05/24/24
Complete List of Cancer Diagnosis Program Initiatives
The Requests for Applications (RFAs) and Program Announcements (PAs) listed below represent both expired and current Funding Opportunities from the Cancer Diagnosis Program and examples of the different type of funding mechanisms used by CDP. This table is intended to keep track of all CDP Funding Opportunities as well as serve as guidance for investigators seeking examples of previously funded projects by the Cancer Diagnosis Program
| Posted Date | Mechanism | Title | Full Details | Expiration | Category |
|---|---|---|---|---|---|
| 12/15/2023 | R01 | National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-24-085 | 01/08/2027 | |
| 11/01/2023 | UH2 / UH3 | Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-23-313 | 10/15/2026 | Assay Development |
| 11/01/2023 | UH3 | Assay Validation for High Quality Markers for Clinical Studies in Cancer | PAR-23-314 | 10/15/2026 | Assay Development |
| 10/06/2023 | R01 | Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants | PAR-24-047 | 10/14/2026 | |
| 09/08/2022 | R01 | Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | PAR-22-243 | 9/08/2025 | Bioengineering Technologies |
| 09/08/2022 | R01 | Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) | PAR-22-242 | 9/08/2025 | Bioengineering Technologies |
| 07/14/2022 | R21 | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | PAR-22-216 | 7/02/2025 | |
| 01/21/2022 | R01 | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) | PAR-22-099 | 5/08/2025 | Cancer TEC |
| 10/22/2021 | U01 | Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) | PAR-22-049 | 9/14/2024 | |
| 3/25/2021 | R01 | Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) | PAR-21-166 | 09/08/2024 | |
| 11/10/2020 | R01 | National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-21-033 | 1/8/2024 | |
| 10/13/2020 | UH2 / UH3 | Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) | PAR-20-313 | 10/11/2023 | |
| 10/13/2020 | UH3 | Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) | PAR-20-314 | 10/11/2023 | |
| 9/20/2020 | R21 | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | PAR-20-292 | 7/21/2022 | |
| 12/10/2019 | R01 | Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) | PAR-20-074 | 10/29/2022 | |
| 8/28/2019 | R21 | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | PAR-19-356 | 8/24/2020 | |
| 1/8/2019 | R21 | Exploratory/Developmental Bioengineering Research Grants(EBRG) (R21 Clinical Trial Not Allowed) | PAR-19-149 | 1/8/2022 | Bioengineering Technologies |
| 1/8/2019 | R21 | Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | PAR-19-150 | 1/8/2022 | Bioengineering Technologies |
| 1/8/2019 | R01 | Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) | PAR-19-158 | 1/8/2022 | Bioengineering Technologies |
| 1/8/2019 | R01 | Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) | PAR-19-159 | 5/8/2022 | Bioengineering Technologies |
| 1/8/2019 | U01 | Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed) | PAR-19-156 | 1/8/2022 | Bioengineering Technologies |
| 1/8/2019 | U01 | Bioengineering Research Partnerships (U01 Clinical Trial Required) | PAR-19-157 | 1/8/2022 | Bioengineering Technologies |
| 2/28/2018 | R01 | Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) | PAR-18-530 | 3/25/2021 | |
| 1/5/2018 | R01 | National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-18-560 | 11/12/2020 | |
| 11/17/2017 | R21 | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | PAR-18-020 | 3/23/2019 | |
| 11/13/2017 | R21 | Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | PA-18-286 | 1/8/2019 | Bioengineering Technologies |
| 11/7/2017 | R01 | Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | PAR-18-206 | 1/8/2019 | Bioengineering Technologies |
| 11/7/2017 | U01 | Bioengineering Research Partnerships (U01 Clinical Trial Optional) | PAR-18-208 | 1/8/2019 | Bioengineering Technologies |
| 5/10/2016 | R01 | Bioengineering Research Grants (BRG) (R01) | PAR-16-242 | 1/24/2018 | Bioengineering Technologies |
| 4/8/2016 | R21 | NCI Clinical and Translational Exploratory/Developmental Studies (R21) | PAR-16-176 | 1/24/2018 | |
| 11/20/2015 | R21 | Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)s | PA-16-040 | 6/28/2018 | Bioengineering Technologies |
| 12/16/2016 | U24 | Cancer Immune Monitoring and Analysis Centers (CIMACs) | RFA-CA-17-005 | 3/17/2017 | |
| 12/16/2016 | U24 | Cancer Immunologic Data Commons (CIDC) | RFA-CA-17-006 | 3/17/2017 | |
| 10/4/2016 | R01 | Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants | PAR-17-003 | 10/29/2019 | |
| 4/5/2016 | U01 | Integrating Biospecimen Science Approaches into Clinical Assay Development | PAR-16-166 | 5/23/2018 | |
| 01/21/2015 | UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II | Assay Validation For High Quality Markers For NCI-Supported Clinical Trials | PAR-15-095 | 10/07/2017 | Assay Development |
| 01/21/2015 | UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II | Assay Validation For High Quality Markers For NCI-Supported Clinical Trials | PAR-15-096 | 10/07/2017 | Assay Development |
| 11/24/2014 | UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II | Cancer Detection, Diagnosis, and Treatment Technologies for Global Health | RFA-CA-15-001 | 03/07/2015 | Global Health |
| 06/05/2014 | U24 — Resource-Related Research Project-Cooperative Agreement | Limited Competition: Biospecimen Banks to Support NCI-Clinical Trials Network (NCTN) | RFA-CA-14-501 | 08/16/2014 | Biospecimen Resource |
| 12/20/2013 | R21 — NIH Exploratory/ Developmental Research Grant Award | Early-Stage Innovative Molecular AnalysisTechnology Development for Cancer Research | RFA-CA-14-003 (R21) | 09/19/2014 | Technology Development |
| 12/20/2013 | R33 — NIH Exploratory/ Developmental Research Grant Award Phase II | Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research | RFA-CA-14-004 (R33) | 09/19/2014 | Technology Development |
| 12/20/2013 | R21 — NIH Exploratory/ Developmental Research Grant Award | Early-Stage Development of Innovative Technologies for Biospecimen Science | RFA-CA-14-005 (R21) | 09/19/2014 | Technology Development |
| 12/20/2013 | R33 — NIH Exploratory/ Developmental Research Grant Award Phase II | Validation and Advanced Development of Emerging Technologies for Biospecimen Science | RFA-CA-14-006 (R33) | 09/19/2014 | Technology Development |
| 10/30/2013 | UH2/UH3 — Exploratory/ Developmental Cooperative Agreement Phase I & Phase II | Cancer Detection, Diagnosis, and Treatment Technologies for Global Health | RFA-CA-13-015 (UH2/UH3) | 01/07/2014 | Global Health |
| 04/05/2013 | R01 — NIH Research Project Grant Program | Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations | PAR-13-169 (R01) | 05/08/2016 | |
| 03/19/2013 | R21 — NIH Exploratory/ Developmental Research Grant Award | NCI Exploratory/ Developmental Research Grant Program | PAR-13-146 (R21) | 09/05/2015 | Exploratory Studies |
| 02/21/2013 | UM1 Multi-component Research Project – Cooperative Agreements | Collaborative Human Tissue Network (CHTN) (UM1) | RFA-CA-13-007 (UM1) | 06/01/2013 | Human Tissue Specimen Resources |
| 12/21/2011 | R21 — NIH Exploratory/ Developmental Research Grant Award | Early-Stage Innovative Technology Development for Cancer Research | RFA-CA-12-002 (R21) | 09/19/2012 | Technology Development |
| 12/21/2011 | R33 — NIH Exploratory/ Developmental Research Grant Award Phase II | Validation and Advanced Development of Emerging Technologies for Cancer Research | RFA-CA-12-003 (R33) | 09/19/2012 | Technology Development |
| 11/16/2011 | R01 — NIH Research Project Grant Program | Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials | PA-12-013 (R01) | 01/08/2015 | |
| 11/16/2011 | R21 — NIH Exploratory/ Developmental Research Grant Award | Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials | PA-12-014 (R21) | 01/08/2015 | |
| 08/09/2011 | R21 — NIH Exploratory/ Developmental Research Grant Award | Pilot Studies in Pancreatic Cancer | PA-11-297 (R21) | 01/08/2015 | |
| 08/09/2011 | R03 — NIH Small Grant Program | Pilot Studies in Pancreatic Cancer | PA-11-298 (R03) | 01/08/2015 | |
| 09/29/2010 | Request for Proposal (RFP) — Solicitation | RECOVERY — Comprehensive Data Resource (CDR) | RFP No. ST10-1124 | 10/27/2010 | Biospecimen Resource |
| 09/01/2010 | Request for Proposal (RFP) — Solicitation | RECOVERY — Biospecimen Source Sites for Procurement of Cancer Biospecimens (formerly RFP No. ST10-1039) | RFP No. ST10-1105 | 10/12/2010 | Biospecimen Resource |
| 07/21/2010 | R01 — NIH Research Project Grant Program | Bioengineering Research Partnerships (BRP) | PAR-10-234 (R01) | 01/08/2014 | Technology Development |
| 04/06/2010 | R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II | Bioengineering Nanotechnology Initiative | PA-10-149 (STTR — R41/R42) | 05/08/2013 | Technology Development |
| 04/06/2010 | R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II | Bioengineering Nanotechnology Initiative | PA-10-150 (SBIR — R43/R44) | 05/08/2013 | Technology Development |
| 03/18/2010 | Request for Proposal (RFP) — Solicitation | RECOVERY — Comprehensive Biospecimen Resource | RFP No. ST10-1035 | 06/17/2010 | Biospecimen Resource |
| 11/17/2009 | U24 — Resource-Related Research Project — Cooperative Agreement | Limited Competition: Support for Human Specimen Banking in NCI-Supported Clinical Trials — Cooperative Group Banks (CGB) (U24) | RFA-CA-09-504 | 03/31/2015 | Biospecimen Resource |
| 11/16/2009 | Request for Proposal (RFP) — Solicitation | caHUB Acquisition of Normal Tissues | RFP No. S10-084 | 03/12/2010 | Biospecimen Resource |
| 11/16/2009 | R21 — NIH Exploratory/ Developmental Research Grant Award | Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis | PA-10-026 (R21) | 01/08/2013 | Exploratory Studies Clinical Correlative Studies |
| 11/16/2009 | R01 — NIH Research Project Grant Program | Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis | PA-10-025 (R01) | 01/08/2016 | Clinical Correlative Studies |
| 11/03/2009 | Request for Proposal (RFP) – Solicitation | RECOVERY: R&D on Human Biospecimen Integrity | RFP No. ST10-1005 | 12/14/2009 | Biospecimen Research |
| 10/14/2009 | R01 — NIH Research Project Grant Program | Bioengineering Research Grants (BRG) | PA-10-009 (R01) | 03/11/2013 | Technology Development |
| 10/14/2009 | R21 — NIH Exploratory/ Developmental Research Grant Award | Exploratory/ Developmental Bioengineering Research Grants (EBRG) | PA-10-010 (R21) | 01/08/2013 | Technology Development |
| 10/14/2009 | R21 — NIH Exploratory/ Developmental Research Grant Award | Exploratory/ Developmental Bioengineering Research Grants (EBRG) | PA-12-284 (R21) | 01/08/2016 | Technology Development |
| 10/14/2009 | R01 — NIH Research Project Grant Program | Bioengineering Research Grants (BRG) | PAR-13-137 (R01) | 05/08/2016 | Technology Development |
| 07/22/2009 | R21 — NIH Exploratory/ Developmental Research Grant Award | Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis | PA-09-238 (R21) | 09/08/2012 | Technology Development Clinical Correlative Studies |
| 06/01/2009 | R21 — NIH Exploratory/ Developmental Research Grant Award | Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention | PA-09-200 (R21) | 09/08/2012 | Exploratory Studies |
| 05/05/2009 | Request for Proposal (RFP) – Solicitation | Biospecimen Contributing Institutions for Research Studies in Cancer Tissue Pre-Analytical Variables | RFP No. S09-148 | 06/18/2009 | Biospecimen Research |
| 04/17/2009 | R03 — NIH Small Grant Program | Developmental Projects in Complementary Approaches to Cancer Care and Treatment | PA-09-168 (R03) | 05/08/2012 | Exploratory Studies |
| 04/14/2009 | R21 — NIH Exploratory/ Developmental Research Grant Award | Developmental Research in Cancer Prognosis and Prediction | PA-09-158 (R21) | 05/08/2012 | Exploratory Studies Technology Development |
| 04/14/2009 | R33 — NIH Exploratory/ Developmental Research Grant Award Phase II | Developmental Research in Cancer Prognosis and Prediction | PA-09-159 (R33) | 05/08/2012 | Technology Development |
| 04/14/2009 | R21 — NIH Exploratory/ Developmental Research Grant Award | Developmental Research in Cancer Prognosis and Prediction | PA-09-158 (R21) | 05/08/2012 | Clinical Correlative Studies |
| 04/14/2009 | R33 — NIH Exploratory/ Developmental Research Grant Award Phase II | Developmental Research in Cancer Prognosis and Prediction | PA-09-159 (R33) | 05/08/2012 | Clinical Correlative Studies |
| 10/01/2008 | Request for Proposal (RFP) – Solicitation | R&D on Human Biospecimen Integrity | RFP No. S08-280 | 12/09/2008 | Biospecimen Research |
| 09/23/2008 | R21 — NIH Exploratory/ Developmental Research Grant Award | Exploratory Studies in Cancer Detection, Diagnosis and Prognosis | PA-08-267 (R21) | 09/08/2012 | Exploratory Studies Technology Development |
| 07/18/2008 | R21 — NIH Exploratory/ Developmental Research Grant Award | Pilot Studies in Pancreatic Cancer | PA-08-208 (R21) | 09/08/2011 | Exploratory Studies Clinical Correlative Studies |
| 07/18/2008 | R03 — NIH Small Grant Program | Pilot Studies in Pancreatic Cancer | PA-08-209 (R03) | 09/08/2011 | Exploratory Studies Clinical Correlative Studies |
| 04/22/2008 | R01 — NIH Research Project Grant Program | Biomarkers of Infection-Associated Cancers | PA-08-156 (R01) | 05/08/2011 | Clinical Correlative Studies |
| 04/22/2008 | R21 — NIH Exploratory/ Developmental Research Grant Award | Biomarkers of Infection-Associated Cancers | PA-08-157 (R21) | 05/08/2011 | Clinical Correlative Studies |
| 04/22/2008 | R01 — NIH Research Project Grant Program | Biomarkers of Infection-Associated Cancers | PA-11-158 (R01) | 05/08/2014 | |
| 04/22/2008 | R21 — NIH Exploratory/ Developmental Research Grant Award | Biomarkers of Infection-Associated Cancers | PA-11-159 (R21) | 05/08/2014 | |
| 04/11/2008 | R21 — NIH Exploratory/ Developmental Research Grant Award | Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis | PA-08-144 (R21) | 05/08/2011 | Exploratory Studies |
| 04/11/2008 | R01 — NIH Research Project Grant Program | Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis | PA-08-143 (R01) | 05/08/2011 | Clinical Correlative Studies |
| 04/04/2008 | R01 — NIH Research Project Grant Program | Correlative Studies with Specimens from Multi-Site Trials | PA-08-134 (R01) | 11/18/2011 | Clinical Correlative Studies |
| 04/04/2008 | R21 — NIH Exploratory/ Developmental Research Grant Award | Correlative Studies with Specimens from Multi-Site Trials | PA-08-133 (R21) | 05/08/2011 | Clinical Correlative Studies |
| 11/19/2007 | R21 — NIH Exploratory/ Developmental Research Grant Award | Quick-Trials for Novel Cancer Therapies and Prevention: Exploratory Grants | PAR-08-025 (R21) | 11/10/2010 | Clinical Correlative Studies |
| 01/04/2007 | R21 — NIH Exploratory/ Developmental Research Grant Award | Innovations In Cancer Sample Preparation | RFA-CA-07-037 (R21) | 09/28/2007 | Technology Development |
| 01/04/2007 | R33 — NIH Exploratory/ Developmental Research Grant Award Phase II | Innovations In Cancer Sample Preparation | RFA-CA-07-038 (R33) | 09/28/2007 | Technology Development |
| 01/04/2007 | R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II | Innovative Technologies for Molecular Analysis of Cancer | RFA-CA-07-039 (SBIR — R43/R44) | 09/29/2007 | Small Business |
| 01/04/2007 | R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II | Innovative Technologies for Molecular Analysis of Cancer | RFA-CA-07-040 (STTR — R41/R42) | 09/29/2007 | Small Business |
| 01/04/2007 | R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II | Application of Emerging Technology For Cancer Research | RFA-CA-07-041 (SBIR — R43/R44) | 09/29/2007 | Small Business |
| 01/04/2007 | R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II | Application of Emerging Technology For Cancer Research | RFA-CA-07-042 (STTR — R41/R42) | 09/29/2007 | Small Business |
| 01/04/2007 | R43/R44 — NIH Small Business Technology Transfer (SBIR) Grants Phase I & II | Innovations In Cancer Sample Preparation | RFA-CA-07-043 (SBIR — R43/R44) | 09/29/2007 | Small Business |
| 01/04/2007 | R41/R42 — NIH Small Business Technology Transfer (STTR) Grants Phase I & II | Innovations In Cancer Sample Preparation | RFA-CA-07-044 (STTR — R41/R42) | 09/29/2007 | Small Business |
| 04/27/2006 | R21 — NIH Exploratory/ Developmental Research Grant Award | In Vivo Cancer Imaging Exploratory/ Developmental Grants | PA-06-371 (R21) | 05/08/2009 | Exploratory Studies |